These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29499628)

  • 1. In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR
    Blanco F; Heinonen SE; Gurzeler E; Berglund LM; Dutius Andersson AM; Kotova O; Jönsson-Rylander AC; Ylä-Herttuala S; Gomez MF
    Diab Vasc Dis Res; 2018 Jul; 15(4):302-313. PubMed ID: 29499628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
    Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
    Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
    Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice.
    Heinonen SE; Merentie M; Hedman M; Mäkinen PI; Loponen E; Kholová I; Bosch F; Laakso M; Ylä-Herttuala S
    Cardiovasc Diabetol; 2011 Jun; 10():59. PubMed ID: 21718508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia.
    Heinonen SE; Leppänen P; Kholová I; Lumivuori H; Häkkinen SK; Bosch F; Laakso M; Ylä-Herttuala S
    Circ Res; 2007 Nov; 101(10):1058-67. PubMed ID: 17872464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early development of calcific aortic valve disease and left ventricular hypertrophy in a mouse model of combined dyslipidemia and type 2 diabetes mellitus.
    Le Quang K; Bouchareb R; Lachance D; Laplante MA; El Husseini D; Boulanger MC; Fournier D; Fang XP; Avramoglu RK; Pibarot P; Deshaies Y; Sweeney G; Mathieu P; Marette A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2283-91. PubMed ID: 25231636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice.
    Rensing KL; de Jager SC; Stroes ES; Vos M; Twickler MT; Dallinga-Thie GM; de Vries CJ; Kuiper J; Bot I; von der Thüsen JH
    Cardiovasc Res; 2014 Feb; 101(2):277-87. PubMed ID: 24220638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [
    Hellberg S; Sippola S; Liljenbäck H; Virta J; Silvola JMU; Ståhle M; Savisto N; Metso J; Jauhiainen M; Saukko P; Ylä-Herttuala S; Nuutila P; Knuuti J; Roivainen A; Saraste A
    Atherosclerosis; 2017 Aug; 263():369-376. PubMed ID: 28457625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice.
    Theelen TL; Lappalainen JP; Sluimer JC; Gurzeler E; Cleutjens JP; Gijbels MJ; Biessen EA; Daemen MJ; Alitalo K; Ylä-Herttuala S
    Atherosclerosis; 2015 Aug; 241(2):297-304. PubMed ID: 26062989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).
    Sanan DA; Newland DL; Tao R; Marcovina S; Wang J; Mooser V; Hammer RE; Hobbs HH
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4544-9. PubMed ID: 9539774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Calcific Aortic Valve Disease in response to a diabetogenic, procalcific diet in the LDLr
    Scatena M; Jackson MF; Speer MY; Leaf EM; Wallingford MC; Giachelli CM
    Cardiovasc Pathol; 2018; 34():28-37. PubMed ID: 29539583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
    Adamson SE; Polanowska-Grabowska R; Marqueen K; Griffiths R; Angdisen J; Breevoort SR; Schulman IG; Leitinger N
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1020-1029. PubMed ID: 29599136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr
    Zhao L; Cozzo AJ; Johnson AR; Christensen T; Freemerman AJ; Bear JE; Rotty JD; Bennett BJ; Makowski L
    Atherosclerosis; 2017 Nov; 266():182-189. PubMed ID: 29035781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial Oxidative Stress Promotes Atherosclerosis and Neutrophil Extracellular Traps in Aged Mice.
    Wang Y; Wang W; Wang N; Tall AR; Tabas I
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):e99-e107. PubMed ID: 28596373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic mice.
    Zetterqvist AV; Berglund LM; Blanco F; Garcia-Vaz E; Wigren M; Dunér P; Andersson AM; To F; Spegel P; Nilsson J; Bengtsson E; Gomez MF
    PLoS One; 2014; 8(6):e65020. PubMed ID: 23755169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.
    Park JG; Xu X; Cho S; Lee AH
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1772-81. PubMed ID: 27417587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDLR-/-ApoB100/100 mice with insulin-like growth factor II overexpression reveal a novel form of retinopathy with photoreceptor atrophy and altered morphology of the retina.
    Kinnunen K; Heinonen SE; Kalesnykas G; Laidinen S; Uusitalo-Järvinen H; Uusitalo H; Ylä-Herttuala S
    Mol Vis; 2013; 19():1723-33. PubMed ID: 23922490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral factors secreted from adipose tissue-derived mesenchymal stem cells ameliorate atherosclerosis in Ldlr-/- mice.
    Takafuji Y; Hori M; Mizuno T; Harada-Shiba M
    Cardiovasc Res; 2019 May; 115(6):1041-1051. PubMed ID: 30388208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
    Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.